ViroCell Biologics
Home
Conferences Careers Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Innovation Research Vector design & optimization Process Development GMP manufacturing
In the News Press Releases
Home Who We Are Leadership Team Scientific Advisory Board Board of Directors What we do Innovation Research Vector design & optimization Process Development GMP manufacturing
ViroCell Biologics
Conferences Newsroom In the News Press Releases CareersContact Us

Introducing ViroCell Biologics

MORE
In the NewsFlorence BuchananApril 28, 2021CDMO, clinical trials, viral vectors, cell and gene therapies
LinkedIn0 0 Likes
Previous

First UK-based clinical trial focused viral vector manufacturer announces launch

In the NewsFlorence BuchananApril 29, 2021CDMO, clinical trials, viral vectors, cell and gene therapies, ViroCell, Farzin Farzaneh, Truell Conservation Foundation, John Hadden II, gene therapy, cell therapy, CGT, UK CDMO, UR ALL news, vector design, AAV vectors, lentivirus vectors
Next

Introducing ViroCell Biologics. The UK’s first clinical trial focused viral vector manufacturer.

In the NewsFlorence BuchananApril 28, 2021CDMO, ViroCell, viral vector, viral vectors, AAV vectors, lentivirus vectors, gene therapy, cell therapy, CGT, Farzin Farzaneh, John W. Hadden II, Contract Pharma, UK CDMO, vector design
NewsroomCareersContact UsTerms of UsePrivacy Notice

London New York

 

©2024 ViroCell Biologics, Ltd. All rights reserved.